SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-221460 from Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings, Inc.
Date: Aug. 25, 2023 · CIK: 0001830214 · Accession: 0001193125-23-221460

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-274171

Date
August 29, 2023
Author
Mark Dmytruk
Form
CORRESP
Company
Ginkgo Bioworks Holdings, Inc.

Letter

Ginkgo Bioworks Holdings, Inc.

27 Drydock Avenue

8th Floor

Boston, MA 02210

August 25,

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Daniel Crawford

Re: Ginkgo Bioworks Holdings, Inc.

Registration Statement on Form S-3 (File No. 333-274171)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 29, 2023, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

Please contact Marko Zatylny (marko.zatylny@ropesgray.com) / telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective.

[Signature page follows]

Very truly yours,
GINKGO BIOWORKS HOLDINGS, INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Ginkgo Bioworks Holdings, Inc.

27 Drydock Avenue

 8th Floor

Boston, MA 02210

 August 25,
2023

 VIA EDGAR

 Securities and Exchange
Commission

 Division of Corporation Finance

 100 F Street,
N.E.

 Washington, D.C. 20549

Attention:
 Daniel Crawford

          Re:
 Ginkgo Bioworks Holdings, Inc.

 Registration Statement on Form S-3 (File
No. 333-274171)

 Request for Acceleration

Ladies and Gentlemen:

 Pursuant to Rule 461 of the General Rules
and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for
the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 29, 2023, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes &
Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

 Please contact Marko Zatylny (marko.zatylny@ropesgray.com)
/ telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective.

[Signature page follows]

Very truly yours,

GINKGO BIOWORKS HOLDINGS, INC.

By:

 /s/ Mark Dmytruk

Name:

Mark Dmytruk

Title:

Chief Financial Officer

 [Signature Page to Acceleration Request]